Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Winer

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|August 22, 2017
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302)Judith O Hopkins, Jake Allred, Arti Hurria, et al.
The Oncologist|August 5, 2015
Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast CancerDavinia S Seah, Sarah Scott, Hao Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104Ann H Partridge, Laura Archer, Alice B Kornblith, et al.
Breast Cancer Research : BCR|September 7, 2018
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancerPatrick Schöffski, Sara Cresta, Ingrid A Mayer, et al.
Breast Cancer Research and Treatment|December 25, 2014
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancerSara Tolaney, Howard Burris, Elaina Gartner, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancerSharon Galper, Emily Blood, Rebecca Gelman, et al.
Breast Cancer Research and Treatment|April 2, 2017
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Ling Cai, George Luta, et al.
JAMA|March 3, 2005
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancerHyman B Muss, Susan Woolf, Donald Berry, et al.
American Journal of Clinical Pathology|December 17, 2023
HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancerDaniel Xia, Frank Kuo, Melissa Hughes, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancerJoyce F Liu, Sara M Tolaney, Michael Birrer, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|August 22, 2017
Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302)Judith O Hopkins, Jake Allred, Arti Hurria, et al.
The Oncologist|August 5, 2015
Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast CancerDavinia S Seah, Sarah Scott, Hao Guo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104Ann H Partridge, Laura Archer, Alice B Kornblith, et al.
Breast Cancer Research : BCR|September 7, 2018
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancerPatrick Schöffski, Sara Cresta, Ingrid A Mayer, et al.
Breast Cancer Research and Treatment|December 25, 2014
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancerSara Tolaney, Howard Burris, Elaina Gartner, et al.
International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancerSharon Galper, Emily Blood, Rebecca Gelman, et al.
Breast Cancer Research and Treatment|April 2, 2017
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Ling Cai, George Luta, et al.
JAMA|March 3, 2005
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancerHyman B Muss, Susan Woolf, Donald Berry, et al.
American Journal of Clinical Pathology|December 17, 2023
HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancerDaniel Xia, Frank Kuo, Melissa Hughes, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancerJoyce F Liu, Sara M Tolaney, Michael Birrer, et al.
Pageof 11